• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Endoscopy International Open >The EDGI new take on EDGE: EUS-directed transgastric intervention (EDGI), other than ERCP, for Roux-en-Y gastric bypass anatomy: a multicenter study
【24h】

The EDGI new take on EDGE: EUS-directed transgastric intervention (EDGI), other than ERCP, for Roux-en-Y gastric bypass anatomy: a multicenter study

机译：EDGI新的采取边缘：EUS定向的僵化干预（EDGI）除ERCP之外，对于Roux-Zh-Y胃旁路解剖学：多中心的研究

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background and study aims?Indications for accessing the duodenum, and/or excluded stomach in Roux-en-Y gastric bypass (RYGB) patients extend beyond diagnosis and treatment of pancreaticobiliary maladies. Given the high technical and clinical success of EUS-directed transgastric ERCP (EDGE) in RYGB anatomy, we adopted this transgastric (anterograde) approach to evaluate and treat luminal and extraluminal pathology in and around the excluded gut in RYGB patients. EUS-directed transgastric intervention (“EDGI”), other than ERCP, is the terminology we have chosen to describe this heterogenous group of transgastric diagnostic and/or interventional endoscopic procedures (transgastric interventions) performed via a lumen-apposing mental stent (LAMS) in select patients with RYGB. Patients and methods?A multicenter (n?=?4), retrospective study of RYGB patients with suspected luminal or extraluminal pathology, in or around the duodenum and/or excluded stomach, underwent EDGI using LAMS between December 2015 and January 2019. Results?A total of 14 patients (78.6?% women; mean age, 55.7?+?12.4 years) underwent EDGI via LAMS. Technical and clinical success rates of EDGI were 100?%. The most common transgastric interventions were diagnostic EUS of extraluminal pathology (n?=?6, 42.7?%) and endoscopic biopsy of gastroduodenal luminal abnormalities (n?=?5, 35.7?%). Two moderate-severity adverse events due to LAMS maldeployment occurred during EUS-JG creation (14.3?%), and each instance was successfully rescued with a bridging stent. Conclusions?A variety of gastroduodenal luminal and extraluminal disorders in RYGB patients can be effectively diagnosed and managed using EDGI via LAMS.
机译：背景和研究目标？用于访问十二指肠的指示和/或排除在Roux-Zh-Y胃旁路（RYGB）患者中延伸超越胰腺杂种疫苗的诊断和治疗。鉴于RYGB解剖学中EUS定向的血肿性ERCP（EDGE）的高技术和临床成功，我们采用这种综条（朝向）方法在RYGB患者中排除的肠道内和周围的腔内和外形病理学。 EUS定向的综痛性干预（“EDGI”）除ERCP之外，我们选择通过腔上索取精神支架（林）进行的临床诊断和/或介入内窥镜手术（血管内干预）的术语。在选择RygB患者中。患者和方法？多中心（n？=？4），对患有呼吸腔或外肿瘤病理学的RYGB患者的回顾性研究，在十二指肠和/或被排除在外的胃部，在2015年12月和2019年1月期间使用LAMS进行EDGI。结果？共有14名患者（78.6？％女性;平均年龄，55.7？+ 12.4岁）通过林进行Edgi。 Edgi的技术和临床成功率为100？％。最常见的综痛性干预是诊断EUS的外形病理学（n？=Δ6,42.7？％）和内镜术治疗的内窥镜活检（n？=Δ5,35.7？％）。由于leam maldepale overs发生的两个中等严重程度不良事件发生在EUS-JG创建期间（14.3？％），并且每个实例都以桥接支架成功救出。结论？使用Edgi通过林可有效地诊断和管理RyGB患者中的各种胃泌素腔和外耳癌障碍。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号